NCT02026960View on ClinicalTrials.gov

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

NATerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

September 7, 2017

Conditions

Metastatic Renal Cell CarcinomaGenitourinary Cancer (Bladder, Prostate or Testicular)

Interventions

DEVICE

RNA extraction and amplification from biopsy specimens

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Argos Therapeutics

All Listed Sponsors

collaborator

Argos Therapeutics

INDUSTRY

lead

Duke University

OTHER

NCT02026960 - RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017) | Biotech Hunter | Biotech Hunter